$469.77
Price
$21.2B
Market Cap
17.8
P/E Ratio
16.1
Forward P/E
$26.40
EPS (TTM)
—
Dividend Yield
$2.8B
Cash
$300M
Total Debt
43M
Shares Out
$266.98
$519.99
52-Week Range
Institutional Ownership of UNITED THERAPEUTICS CORP DEL
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for UNITED THERAPEUTICS CORP DEL
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2024-Q3 | |||||
| SELL | EXIT | — | — | $336.74 | |
| 2024-Q2 | |||||
| SELL | -23.8% | 1.6K | $509361 | $267.72 | |
| 2024-Q1 | |||||
| BUY | +3.7% | 2.1K | $481723 | $223.58 | |
| 2023-Q4 | |||||
| BUY | +8.5% | 2.0K | $444618 | $228.99 | |
| 2023-Q3 | |||||
| SELL | -10.2% | 1.9K | $420796 | $229.81 | |
| 2023-Q2 | |||||
| BUY | +21.6% | 2.1K | $457836 | $223.07 | |
| 2023-Q1 | |||||
| BUY | NEW | 1.7K | $381852 | $253.14 | |
| 2022-Q2 | |||||
| SELL | EXIT | — | — | $190.11 | |
| 2022-Q1 | |||||
| BUY | +7.0% | 2.8K | $497000 | $196.50 | |
| 2021-Q4 | |||||
| SELL | -7.5% | 2.6K | $559000 | $193.93 | |
| 2021-Q3 | |||||
| BUY | +21.8% | 2.8K | $516000 | $200.47 | |
| 2021-Q2 | |||||
| BUY | NEW | 2.3K | $412000 | $191.38 | |
| 2021-Q1 | |||||
| SELL | EXIT | — | — | $167.68 | |
| 2020-Q4 | |||||
| SELL | -15.8% | 4.3K | $651000 | $135.08 | |
| 2020-Q3 | |||||
| SELL | -3.5% | 5.1K | $514000 | $109.47 | |
| 2020-Q2 | |||||
| BUY | NEW | 5.3K | $639000 | $114.15 | |
Insider Trading for UNITED THERAPEUTICS CORP DEL
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.